What is the current annual cash & cash equivalents of AZN?

As of today, AZN annual cash & cash equivalents is $5.74B

What is 1-year change in AZN annual cash & cash equivalents?

AZN annual cash & cash equivalents is up +1.54% year-over-year

What is 3-year change in AZN annual cash & cash equivalents?

AZN annual cash & cash equivalents is down -10.37% over the past 3 years

How far is AZN annual cash & cash equivalents from its all-time high?

AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013

How does AZN annual cash & cash equivalents rank versus sector peers?

AZN annual cash & cash equivalents is higher than 97.96% of companies in Healthcare sector

When is AZN next annual earnings release?

The next annual earnings release for AZN is on February 9, 2027

What is the current quarterly cash & cash equivalents of AZN?

As of today, AZN quarterly cash & cash equivalents is $7.94B

What is AZN quarterly cash & cash equivalents most recent change?

AZN quarterly cash & cash equivalents was up +62.19% on September 30, 2026

What is 1-year change in AZN quarterly cash & cash equivalents?

AZN quarterly cash & cash equivalents is down -3.01% year-over-year

How far is AZN quarterly cash & cash equivalents from its all-time high?

AZN quarterly cash & cash equivalents is currently -49.22% below its historical high of $15.63B set on June 30, 2021

How does AZN quarterly cash & cash equivalents rank versus sector peers?

AZN quarterly cash & cash equivalents is higher than 98.66% of companies in Healthcare sector

When is AZN next earnings release?

The next earnings release for AZN is on February 9, 2027

AstraZeneca PLC (AZN) Cash & Equivalents History & Chart

Annual Cash & Cash Equivalents

$5.74B$87.00M+1.54%

December 31, 2025

Summary

Current Value: As of today, AZN annual cash & cash equivalents is $5.74B, up +1.54% on December 31, 2025
Historical Performance: AZN annual cash & cash equivalents is down -10.37% over the past 3 years, down -28.17% over the past 5 years
All-Time High Comparison: AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013
3-Year Low Comparison: AZN annual cash & cash equivalents is +1.54% above its 3-year low of $5.65B reached on December 31, 2024
Sector Comparison: AZN annual cash & cash equivalents is higher than 97.96% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

AZN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$5.74B	+1.5%	-10.4%	-28.2%	–
Quarterly Cash & Cash Equivalents	Sep 30, 26	$7.94B	-3.0%	+55.1%	+11.0%	-26.6%
Price	Nov 12, 26	$184.38	+110.3%	+191.9%	+213.6%	+692.0%
Annual Current Assets	Dec 31, 25	$28.72B	+11.2%	+27.1%	+47.0%	+14.1%
Annual Total Liabilities	Dec 31, 25	$65.30B	+3.4%	+9.9%	+27.8%	+99.6%
Annual Working Capital	Dec 31, 25	-$1.89B	+7.1%	+48.8%	-148.2%	-123.1%
Annual Net Income	Dec 31, 25	$10.26B	+45.6%	+211.5%	+226.2%	+26.8%

Cash and Cash Equivalents Highs

AZN Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$6.41B	N/A	-10.4%
5Y	$7.99B	N/A	-28.2%
All	$10.05B	Dec 31, 13	-42.9%

Cash and Cash Equivalents Lows

AZN Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$5.65B	Dec 31, 24	+1.5%
5Y	$5.65B	Dec 31, 24	+1.5%
All	$613.10M	Dec 31, 90	+836.4%

Cash and Cash Equivalents History

Year	Value	Change
2025	$5.74B	+1.5%
2024	$5.65B	-5.2%
2023	$5.96B	-6.9%
2022	$6.41B	+0.1%
2021	$6.40B	-19.9%
2020	$7.99B	+28.5%
2019	$6.22B	+9.5%
2018	$5.68B	+24.0%
2017	$4.58B	-22.7%
2016	$5.93B	-13.5%
2015	$6.86B	-4.5%
2014	$7.18B	-28.6%
2013	$10.05B	+17.5%

Year	Value	Change
2012	$8.56B	+66.2%
2004	$5.15B	+30.2%
2003	$3.95B	-15.7%
2002	$4.69B	+659.5%
1998	$617.27M	-48.5%
1997	$1.20B	-28.1%
1996	$1.67B	+35.7%
1995	$1.23B	+6.9%
1994	$1.15B	-26.0%
1993	$1.55B	+145.6%
1992	$633.02M	-3.1%
1991	$653.08M	+6.5%
1990	$613.10M	-

FAQ

What is the current annual cash & cash equivalents of AZN?: As of today, AZN annual cash & cash equivalents is $5.74B
What is 1-year change in AZN annual cash & cash equivalents?: AZN annual cash & cash equivalents is up +1.54% year-over-year
What is 3-year change in AZN annual cash & cash equivalents?: AZN annual cash & cash equivalents is down -10.37% over the past 3 years
How far is AZN annual cash & cash equivalents from its all-time high?: AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013
How does AZN annual cash & cash equivalents rank versus sector peers?: AZN annual cash & cash equivalents is higher than 97.96% of companies in Healthcare sector
When is AZN next annual earnings release?: The next annual earnings release for AZN is on February 9, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$7.94B$3.04B+62.19%

September 30, 2026

Summary

Current Value: As of today, AZN quarterly cash & cash equivalents is $7.94B, up +62.19% on September 30, 2026
Historical Performance: AZN quarterly cash & cash equivalents is down -3.01% year-over-year, up +55.15% over the past 3 years
All-Time High Comparison: AZN quarterly cash & cash equivalents is currently -49.22% below its historical high of $15.63B set on June 30, 2021
3-Year Low Comparison: AZN quarterly cash & cash equivalents is +62.19% above its 3-year low of $4.89B reached on June 30, 2026
Sector Comparison: AZN quarterly cash & cash equivalents is higher than 98.66% of companies in Healthcare sector

Performance

AZN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 26	$7.94B	+62.2%	-3.0%	+55.1%	+11.0%
Annual Cash & Cash Equivalents	Dec 31, 25	$5.74B	–	+1.5%	-10.4%	-28.2%
Price	Nov 12, 26	$184.38	+16.3%	+110.3%	+191.9%	+213.6%
Quarterly Current Assets	Sep 30, 26	$31.45B	+12.4%	+5.0%	+39.8%	+17.8%
Quarterly Total Liabilities	Sep 30, 26	$68.11B	+4.0%	-0.6%	+15.7%	+1.2%
Quarterly Working Capital	Sep 30, 26	$181.00M	+105.0%	+104.4%	+103.0%	-94.0%
Quarterly Net Income	Sep 30, 26	$3.12B	+24.3%	+23.7%	+126.2%	+288.8%

Quarterly Cash & Cash Equivalents Highs

AZN Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$8.18B	N/A	-3.0%
3Y	$8.18B	Sep 30, 25	-3.0%
5Y	$8.18B	Sep 30, 25	-3.0%
All	$15.63B	Jun 30, 21	-49.2%

Quarterly Cash & Cash Equivalents Lows

AZN Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$4.89B	Jun 30, 26	+62.2%
3Y	$4.89B	Jun 30, 26	+62.2%
5Y	$4.89B	Jun 30, 22	+62.4%
All	$0.00	Mar 31, 00	N/A

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$7.94B	+62.2%
Jun 2026	$4.89B	-36.2%
Mar 2026	$7.68B	+33.7%
Dec 2025	$5.74B	-29.8%
Sep 2025	$8.18B	+15.1%
Jun 2025	$7.11B	+31.8%
Mar 2025	$5.40B	-4.6%
Dec 2024	$5.65B	+14.7%
Sep 2024	$4.93B	-30.3%
Jun 2024	$7.08B	-11.8%
Mar 2024	$8.02B	+34.5%
Dec 2023	$5.96B	+16.6%
Sep 2023	$5.12B	-12.0%
Jun 2023	$5.81B	-10.1%
Mar 2023	$6.46B	+0.9%
Dec 2022	$6.41B	+30.8%
Sep 2022	$4.90B	+0.2%
Jun 2022	$4.89B	-16.1%
Mar 2022	$5.82B	-9.0%
Dec 2021	$6.40B	-10.5%
Sep 2021	$7.15B	-54.3%
Jun 2021	$15.63B	+101.3%
Mar 2021	$7.77B	-2.8%
Dec 2020	$7.99B	-5.4%
Sep 2020	$8.45B	+38.1%
Jun 2020	$6.12B	+46.8%
Mar 2020	$4.17B	-33.0%
Dec 2019	$6.22B	+30.1%
Sep 2019	$4.78B	-23.5%
Jun 2019	$6.25B	+26.0%
Mar 2019	$4.96B	-12.7%
Dec 2018	$5.68B	+33.3%
Sep 2018	$4.26B	+11.9%
Jun 2018	$3.81B	-1.6%
Mar 2018	$3.87B	-15.5%
Dec 2017	$4.58B	-12.1%
Sep 2017	$5.21B	-16.8%
Jun 2017	$6.26B	+70.6%
Mar 2017	$3.67B	-38.1%
Dec 2016	$5.93B	+47.3%
Sep 2016	$4.03B	-13.5%
Jun 2016	$4.65B	+13.2%
Mar 2016	$4.11B	-40.1%
Dec 2015	$6.86B	+48.8%
Sep 2015	$4.61B	+1.3%
Jun 2015	$4.55B	+22.2%
Mar 2015	$3.72B	-48.1%

Month	Value	Change
Dec 2014	$7.18B	+20.5%
Sep 2014	$5.96B	+3.1%
Jun 2014	$5.78B	+11.9%
Mar 2014	$5.16B	-48.6%
Dec 2013	$10.05B	+20.5%
Sep 2013	$8.34B	-8.3%
Jun 2013	$9.10B	+13.3%
Mar 2013	$8.03B	-6.1%
Dec 2012	$8.56B	+25.5%
Sep 2012	$6.82B	-25.9%
Jun 2012	$9.20B	-8.0%
Mar 2012	$10.00B	-7.5%
Sep 2011	$10.81B	+5.0%
Jun 2011	$10.30B	-4.6%
Mar 2011	$10.79B	-6.8%
Sep 2010	$11.58B	+4.7%
Jun 2010	$11.05B	+17.6%
Mar 2010	$9.40B	+29.2%
Jun 2009	$7.27B	+60.7%
Mar 2009	$4.52B	+24.7%
Sep 2008	$3.63B	-19.5%
Jun 2008	$4.51B	+38.5%
Mar 2008	$3.26B	-54.1%
Jun 2006	$7.10B	+17.4%
Mar 2006	$6.05B	+6.9%
Sep 2005	$5.66B	-3.3%
Jun 2005	$5.85B	+20.3%
Mar 2005	$4.86B	+16.0%
Sep 2004	$4.19B	+3.2%
Jun 2004	$4.06B	-2.9%
Mar 2004	$4.18B	-2.4%
Sep 2003	$4.29B	+7.8%
Jun 2003	$3.97B	-5.6%
Jun 2001	$4.21B	+42.9%
Jun 2000	$2.95B	>+9,900.0%
Mar 2000	$0.00	-100.0%
Dec 1999	$429.00M	-88.7%
Sep 1999	$3.79B	+88.1%
Jun 1999	$2.02B	-35.8%
Dec 1998	$3.14B	+859.6%
Jun 1998	$327.00M	-34.7%
Dec 1997	$500.89M	+12.9%
Dec 1996	$443.54M	+76.1%
Dec 1995	$251.87M	-73.8%
Jun 1995	$961.50M	+12.2%
Dec 1994	$856.75M	-36.6%
Dec 1993	$1.35B	-

FAQ

What is the current quarterly cash & cash equivalents of AZN?: As of today, AZN quarterly cash & cash equivalents is $7.94B
What is AZN quarterly cash & cash equivalents most recent change?: AZN quarterly cash & cash equivalents was up +62.19% on September 30, 2026
What is 1-year change in AZN quarterly cash & cash equivalents?: AZN quarterly cash & cash equivalents is down -3.01% year-over-year
How far is AZN quarterly cash & cash equivalents from its all-time high?: AZN quarterly cash & cash equivalents is currently -49.22% below its historical high of $15.63B set on June 30, 2021
How does AZN quarterly cash & cash equivalents rank versus sector peers?: AZN quarterly cash & cash equivalents is higher than 98.66% of companies in Healthcare sector
When is AZN next earnings release?: The next earnings release for AZN is on February 9, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

AZN Official Website www.astrazeneca.com
AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn